1. Home
  2. ZCMD vs CGTX Comparison

ZCMD vs CGTX Comparison

Compare ZCMD & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCMD
  • CGTX
  • Stock Information
  • Founded
  • ZCMD 2012
  • CGTX 2007
  • Country
  • ZCMD China
  • CGTX United States
  • Employees
  • ZCMD N/A
  • CGTX N/A
  • Industry
  • ZCMD Other Consumer Services
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZCMD Real Estate
  • CGTX Health Care
  • Exchange
  • ZCMD Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • ZCMD 35.3M
  • CGTX 30.0M
  • IPO Year
  • ZCMD 2020
  • CGTX 2021
  • Fundamental
  • Price
  • ZCMD $1.45
  • CGTX $0.64
  • Analyst Decision
  • ZCMD
  • CGTX Strong Buy
  • Analyst Count
  • ZCMD 0
  • CGTX 6
  • Target Price
  • ZCMD N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • ZCMD 6.1K
  • CGTX 945.7K
  • Earning Date
  • ZCMD 01-01-0001
  • CGTX 03-25-2025
  • Dividend Yield
  • ZCMD N/A
  • CGTX N/A
  • EPS Growth
  • ZCMD N/A
  • CGTX N/A
  • EPS
  • ZCMD N/A
  • CGTX N/A
  • Revenue
  • ZCMD $17,406,104.00
  • CGTX N/A
  • Revenue This Year
  • ZCMD N/A
  • CGTX N/A
  • Revenue Next Year
  • ZCMD N/A
  • CGTX N/A
  • P/E Ratio
  • ZCMD N/A
  • CGTX N/A
  • Revenue Growth
  • ZCMD 1.01
  • CGTX N/A
  • 52 Week Low
  • ZCMD $1.00
  • CGTX $0.34
  • 52 Week High
  • ZCMD $5.10
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • ZCMD 44.73
  • CGTX 43.76
  • Support Level
  • ZCMD $1.34
  • CGTX $0.60
  • Resistance Level
  • ZCMD $1.51
  • CGTX $0.82
  • Average True Range (ATR)
  • ZCMD 0.11
  • CGTX 0.06
  • MACD
  • ZCMD 0.01
  • CGTX -0.02
  • Stochastic Oscillator
  • ZCMD 39.66
  • CGTX 18.56

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: